Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free ...

This discussion examines the key considerations oncologists weigh when choosing between chemotherapy alone or chemotherapy ...

It’s important to avoid excessive sun exposure because of the problems it causes, from painful sunburn to skin cancer. Like ...

On November 19, 2025, the Food and Drug Administration granted accelerated approval to Bayer’s (BAYRY) sevabertinib, a kinase inhibitor, for ...

Subtle signs of skin cancer you shouldn't ignore When the weather gets warmer and daylight hours longer, people are more likely to spend time outdoors in the sun. This also means there’s an increased ...

The FDA has approved Hyrnuo for some with locally advanced or metastatic non-squamous non–small cell lung cancer with ...

Immunotherapy, which harnesses our body's own immune system to fight cancer, has revolutionized modern oncology. Yet despite ...

This discussion provides an overview of current treatment standards and practical challenges in managing advanced gastric ...

Complex digital images of tissue samples that can take an experienced pathologist up to 20 minutes to annotate could be ...

This important study presents a technically rigorous and carefully controlled analysis of the signalling potential of cancer-associated gain-of-function Notch alleles. The work is clearly presented, ...

The FDA has granted an accelerated approval for the use of sevabertinib in patients with nonsquamous non–small cell lung cancer (NSCLC) whose tumors have HER2 ( ERBB2) tyrosine kinase domain (TKD) ...